Showing 1 - 4 results of 4 for search 'Silke Gastine', query time: 0.02s Refine Results
  1. 1
    Improving the efficacy of plant-made anti-HIV monoclonal antibodies for clinical use

    Improving the efficacy of plant-made anti-HIV monoclonal antibodies for clinical use by Melanie Grandits, Clemens Grünwald-Gruber, Silke Gastine, Joseph F. Standing, Rajko Reljic, Audrey Y-H. Teh, Julian K-C. Ma

    Published 2023-02-01
    Get full text
    Article
  2. 2
    Global antibiotic dosing strategies in hospitalised children: Characterising variation and implications for harmonisation of international guidelines.

    Global antibiotic dosing strategies in hospitalised children: Characterising variation and implications for harmonisation of international guidelines. by Michelle N Clements, Neal Russell, Julia A Bielicki, Sally Ellis, Silke Gastine, Yingfen Hsia, Joseph F Standing, A Sarah Walker, Mike Sharland

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE)

    Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patie... by Tania A. Smith, Carlos Hoyo-Vadillo, Akosua Agyeman Adom, Liliana Favari-Perozzi, Silke Gastine, Hakim-Moulay Dehbi, Beatriz Villegas-Lara, Eduardo Mateos, Yessica Sara Pérez González, Maria D. Navarro-Gualito, Alejandra S. Cruz-Carbajal, Miguel A. Cortes-Vazquez, Carolina Bekker-Méndez, Charmina Aguirre-Alvarado, Gisela Aguirre-Gil, Lucero Delgado-Pastelin, Andrew Owen, David Lowe, Joseph Standing, Jorge Escobedo

    Published 2023-05-01
    Get full text
    Article
  4. 4
    Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE)

    Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated... by Tania Smith, Carlos Hoyo-Vadillo, Akosua Agyeman Adom, Liliana Favari-Perozzi, Silke Gastine, Hakim-Moulay Dehbi, Beatriz Villegas-Lara, Eduardo Mateos, Yessica Sara Pérez González, Maria D. Navarro-Gualito, Alejandra S. Cruz-Carbajal, Miguel A. Cortes-Vazquez, Carolina Bekker-Méndez, Charmina Aguirre-Alvarado, Gisela Aguirre-Gil, Lucero Delgado-Pastelin, Andrew Owen, David Lowe, Joseph Standing, Jorge Escobedo

    Published 2022-07-01
    Get full text
    Article

Search Tools: